Toho HoldingsTOHO HOLDINGS CO.,LTD.8129東証プライム卸売業FY ending Mar 2026, consolidated, J-GAAP
About 92% of Toho Holdings's sales come from Medical products retail, with Dispensing pharmacy and Medical products manufacturing and sales making up much of the rest.
Operating profit was close to zero, a slight profit per ¥100 of sales.
Revenue changed -4.2% from the prior year, operating profit -75.5%.
Revenue -4.2% · profit -75.5%, calculated from disclosed figures.
Operating leverage: 17.86× (profit growth ÷ revenue growth)
FY ending Mar 2020 → FY ending Mar 2021
FY ending Mar 2020 → FY ending Mar 2021
For every ¥100 Toho Holdings sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
Revenue by business segment, and the profit each one keeps.
※ Segment figures include inter-segment sales and do not sum to the company total
EDINET (FSA Japan)
有価証券報告書-第77期(2024/04/01-2025/03/31)
EDINET (FSA Japan)
有価証券報告書-第76期(2023/04/01-2024/03/31)
EDINET (FSA Japan)
有価証券報告書-第75期(2022/04/01-2023/03/31)
EDINET (FSA Japan)
有価証券報告書-第74期(令和3年4月1日-令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書-第73期(令和2年4月1日-令和3年3月31日)
Extracted from XBRL: 54 / Derived from other figures: 2
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.